Company Filing History:
1 out of 1 
1 out of 23 
Years Active: 2021
Title: Bertrand Evrard: Innovator in Gastrointestinal Allergy Solutions
Introduction
Bertrand Evrard is a notable inventor based in Ceyrat, France. He has made significant contributions to the field of allergy treatment, particularly focusing on peanut allergies. His innovative approach has led to the development of a unique gastrointestinal release capsule designed to help patients with peanut allergies.
Latest Patents
Evrard holds a patent for a gastrointestinal release capsule intended for oral use in a method for desensitizing and/or inducing tolerance in peanut-allergic subjects. This capsule is also applicable for diagnosing peanut allergies. The design features a shell and a core, with the core containing a composition of peanut, at least one oil, and at least one first pulverulent excipient, along with an optional second prebiotic excipient. The capsule is ingested in an unopened form, showcasing a novel approach to allergy management.
Career Highlights
Throughout his career, Bertrand Evrard has worked with esteemed institutions such as the Centre Hospitalier et Universitaire de Clermont-Ferrand and Université Clermont Auvergne. His work in these organizations has allowed him to advance his research and contribute to the medical community.
Collaborations
Evrard has collaborated with notable colleagues, including Jean-Luc Fauquert and Elodie Michaud. Their combined expertise has furthered the development of innovative solutions in allergy treatment.
Conclusion
Bertrand Evrard's contributions to the field of allergy treatment through his patented gastrointestinal release capsule highlight his dedication to improving patient outcomes. His work continues to inspire advancements in medical research and innovation.